Patients with an extensive-metabolizing CYP2D6 phenotype have shown higher levels of hydromorphone during hydrocodone metabolism compared to lousy metabolizers.[four] Having said that, the prevailing details does not advocate for altered hydrocodone dosing recommendations for patients with known CYP2D6 polymorphisms.Overdose-relevant pulmonary d